Image Trademark with Serial Number 87052324
Status: 700 - Registered
Image for trademark with serial number 87052324
Serial Number
87052324
Registration Number
5332632
Status
700 - Registered
Status Date
2017-11-14
Filing Date
2016-05-27
Registration Number
5332632
Registration Date
2017-11-14
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s) Typeset
Design Searches
260103 - Incomplete circles (more than semi-circles).
Published for Opposition Date
2017-08-29
Attorney Name
Mark Harrison
Law Office Assigned Location Code
N40
Employee Name
BLAZICH, JOAN MICHELE
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a circle which has a u-shaped portion missing from its central top.
Goods and Services
Chemicals for use in industry and science; chemicals test kits for in vitro testing for laboratory research purposes; biochemicals, namely, monoclonal antibodies and antibody fragments all being proteins for in vitro scientific and laboratory research use; biochemicals, namely, monoclonal antibodies and antibody fragments all being proteins for scientific and laboratory research use; biochemical, namely, monoclonal antibodies and antibody fragments all being protein in raw material form for scientific research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for scientific and laboratory in vitro diagnostic use; antibodies and antibody fragments all being proteins for industrial use in the discovery, preclinical and clinical development of therapeutic products
Goods and Services
Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; veterinary preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; therapeutic pharmaceutical preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes; antibodies being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; antibody fragments being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ and tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; monoclonal antibody therapeutic preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ and tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases; antibodies and antibody fragments being diagnostic reagents for medical and veterinary diagnostics; antibodies and antibody fragments for use in the discovery, preclinical and clinical development of therapeutic products; antibodies and antibody fragments being therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ and tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders and dermatological diseases for use in the manufacture of therapeutic products
Goods and Services
Live animals; live mice
Goods and Services
Treatment and transformation of materials for others, namely, the manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing services in the field of chemicals, biologicals, antibodies and antibody fragments; custom manufacture of therapies using antibodies and antibody fragments
Goods and Services
Scientific and technological services, namely, scientific research, analysis and testing, and research and design in the field of therapeutic pharmaceuticals; scientific laboratory services; laboratory services in the field of antibodies and antibody fragments; research in the field of the development of antibodies and antibody fragments; provision of scientific information in the field of antibodies and antibody fragments for medical and veterinary purposes; engineering of antibodies and antibody fragments; scientific services, namely, the discovery, preclinical and clinical development of therapeutic products; consultancy services relating thereto, namely, therapeutic products
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2016-06-04
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-10-20
Primary Code
005
International Class
031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals, malt. - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals, malt.
US Class Codes
001, 046
Class Status Code
6 - Active
Class Status Date
2016-10-20
Primary Code
031
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-10-20
Primary Code
042
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2016-10-20
Primary Code
040
Current Trademark Owners
Party Name
Crescendo Biologics Limited
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Crescendo Biologics Limited
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Crescendo Biologics Limited
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Crescendo Biologics Limited
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
MARK HARRISON
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2016-04-223160977United KingdomTrue
Trademark Events
Event DateEvent Description
2016-05-31NEW APPLICATION ENTERED IN TRAM
2016-06-04NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-06-07NOTICE OF DESIGN SEARCH CODE E-MAILED
2016-09-12ASSIGNED TO EXAMINER
2016-09-15NON-FINAL ACTION WRITTEN
2016-09-15NON-FINAL ACTION E-MAILED
2016-09-15NOTIFICATION OF NON-FINAL ACTION E-MAILED
2016-10-20TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-10-20CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-10-20TEAS/EMAIL CORRESPONDENCE ENTERED
2016-10-28EXAMINERS AMENDMENT -WRITTEN
2016-10-28EXAMINERS AMENDMENT E-MAILED
2016-10-28NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-10-28EXAMINER'S AMENDMENT ENTERED
2016-10-28SUSPENSION LETTER WRITTEN
2016-10-28LETTER OF SUSPENSION E-MAILED
2016-10-28NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2017-04-28SUSPENSION INQUIRY WRITTEN
2017-04-28INQUIRY TO SUSPENSION E-MAILED
2017-04-28NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2017-06-09TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2017-07-18ASSIGNED TO LIE
2017-07-19CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-07-19TEAS/EMAIL CORRESPONDENCE ENTERED
2017-07-26APPROVED FOR PUB - PRINCIPAL REGISTER
2017-08-09NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-08-29PUBLISHED FOR OPPOSITION
2017-08-29OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-11-14REGISTERED-PRINCIPAL REGISTER